Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable COPD Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
This study expect to investigate psychological intervention (Baduanjin qigong) in COPD patients combined with anxiety and/or depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 4, 2015
CompletedFirst Posted
Study publicly available on registry
April 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedApril 10, 2015
April 1, 2015
5 months
February 4, 2015
April 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
stage of anxiety and depression ((Hospital Anxiety and Depression Scale)
use psychological questionnaires(Hospital Anxiety and Depression Scale,etc)to evaluate the stage of anxiety and/or depression
one year
Secondary Outcomes (2)
the number of acute exacerbations
one year
lung function (pulmonary function test(20 minutes after inhaled 400ug albuterol),the forced expiratory volume in 1 second(FEV1)will be detected)
one year
Study Arms (2)
Baduanjin qigong group
EXPERIMENTALDoing exercise of Baduanjin qigong under the guidance of medical staff;psychological counseling at the same time.
control group
NO INTERVENTIONPsychological counseling only.
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed of COPD
- In stable phase
- FEV1%predicted \<80.
You may not qualify if:
- Cancer
- Severe cerebrovascular disease
- Severe arrhythmia,cardiac insufficiency
- Alzheimer's disease
- Mental illness
- Severe liver disfunction
- Severe renal disfunction
- Physical activity disable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huimin Gonglead
Study Sites (1)
Beijing institute of respiratory diseases
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ting Yang
Capital Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
February 4, 2015
First Posted
April 10, 2015
Study Start
December 1, 2014
Primary Completion
May 1, 2015
Last Updated
April 10, 2015
Record last verified: 2015-04